Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemamali Samaratunga

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
BJU International|September 9, 2022
Low-grade prostate cancer should still be labelled cancerKenneth A Iczkowski, Mariel Molina, Lars Egevad, et al.
European Urology Open Science|June 7, 2023
International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology MembersIrene J Beijert, Liang Cheng, Fredrik Liedberg, et al.
Nature Medicine|January 14, 2022
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challengeWouter Bulten, Kimmo Kartasalo, Po-Hsuan Cameron Chen, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patientsTalia L Fuchs, Fiona Maclean, John Turchini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Journal of Clinical Pathology|January 30, 2021
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international surveyMahmut Akgul, Sean R Williamson, Dilek Ertoy, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
BJU International|September 9, 2022
Low-grade prostate cancer should still be labelled cancerKenneth A Iczkowski, Mariel Molina, Lars Egevad, et al.
European Urology Open Science|June 7, 2023
International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology MembersIrene J Beijert, Liang Cheng, Fredrik Liedberg, et al.
Nature Medicine|January 14, 2022
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challengeWouter Bulten, Kimmo Kartasalo, Po-Hsuan Cameron Chen, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2021
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patientsTalia L Fuchs, Fiona Maclean, John Turchini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Journal of Clinical Pathology|January 30, 2021
Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international surveyMahmut Akgul, Sean R Williamson, Dilek Ertoy, et al.
Pageof 19